iScience Interventional™ is committed to creating breakthrough technologies for sight-threatening diseases.

iScience Interventional™ discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific therapies in the anterior and posterior segments of the eye.

This new category of therapy is called Interventional Ophthalmology. It encompasses procedures such as Anterior Segment Access Technology (ASAT), a microcatheter-based therapy designed to access a wide range of anatomical structures within the anterior segment of the eye; and Posterior Segment Access Technology (PSAT), a method of aspirating ocular fluids or delivering sterile ophthalmic solutions to specific targets in the back of the eye.

Prior to the advent of Interventional Ophthalmology, many anterior and posterior segment diseases had been sub-optimally addressed due to the inability of existing technologies to provide site-specific treatment. At iScience Interventional™, we believe that visualization and access to compromised structures within the eye may dramatically advance how physicians evaluate and manage their patients in the future.

iScience Interventional™ is committed to creating breakthrough technologies for sight-threatening diseases. We look forward to working with you and your colleagues on creating this path to discovery.